Department of Nuclear Medicine, Shiraz Medical Center, Shiraz, Iran
Abstract
Scientimammography (SMM) is a new non-invasive method of imaging breast tumors which in various studies the overall sensitivity of 83%-95.8% and specificity of 52%-95% is reported. The purpose of our study was to evaluate the usefullness of 99mTc-MIBI SMM in our environment in detecting breast cancer and in reducing the rate of biopsy. 65 patients aged 23-70 years were included in this study. The overall sensitivity and specificity of SMM were 84.6% and 71.8% respectively. The PPV of 66.6% and NPV of 87.5% were similar to that obtained by others. These results showed that, SMM did not increase the specificity and PPV of mammography. However SMM is a useful method for evaluating patients with low suspicion or indeterminate mammographic or palpable findings or lesions larger than 1.5 cm.
Falamaki, M., Ghadimi Mahani, M., Alavi, M., Talei, A., & Rasekhi, A. (2002). The role of 99mTc-MIBI scientimammography in diagnosis of breast cancer. Iranian Journal of Nuclear Medicine, 10(2), 7-13.
MLA
Maryam-Naz Falamaki; Maryam Ghadimi Mahani; Mehrosadat Alavi; Abdolrasoul Talei; Alireza Rasekhi. "The role of 99mTc-MIBI scientimammography in diagnosis of breast cancer". Iranian Journal of Nuclear Medicine, 10, 2, 2002, 7-13.
HARVARD
Falamaki, M., Ghadimi Mahani, M., Alavi, M., Talei, A., Rasekhi, A. (2002). 'The role of 99mTc-MIBI scientimammography in diagnosis of breast cancer', Iranian Journal of Nuclear Medicine, 10(2), pp. 7-13.
VANCOUVER
Falamaki, M., Ghadimi Mahani, M., Alavi, M., Talei, A., Rasekhi, A. The role of 99mTc-MIBI scientimammography in diagnosis of breast cancer. Iranian Journal of Nuclear Medicine, 2002; 10(2): 7-13.
)